Alto Ingredients, Inc. ALTO

Healthcare SIC 2860 - Industrial Organic Chemicals NAICS Manufacturing › Chemical Manufacturing › Basic Chemical Manufacturing › Other Basic Organic Chemical Manufacturing derived Nasdaq

alcohols, renewable fuels and essential ingredients in the United States.

We operate five alcohol production facilities.

Three of our production facilities are located in Illinois, one is located in Oregon, and another is located in Idaho. We have an annual

alcohol production capacity of 330 million gallons, including both renewable fuels and specialty alcohols ranging from industrial-, pharmaceutical-,

Last close 3.61 2026-10-23
Market cap $280.0M 2026-06-30 share count
52-week range 0.99 - 6.11

Valuation FY2025 figures against the last close

P/S0.3x
P/E22.6x
P/FCF32.4x
EV/EBITDA10.3x
Dividend yield—
Diluted EPS0.16

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $917.9M$965.3M$1.22B$1.34B$1.21B$897.0M$1.42B$1.52B$1.63B$1.62B
Cost of revenue $883.0M$955.5M$1.21B$1.36B$1.14B$844.2M$1.43B$1.53B$1.63B$1.57B
Gross profit $34.9M$9.7M$15.7M-$27.6M$67.8M$52.9M-$9.9M-$15.2M$5.9M$54.4M
SG&A $27.2M$29.7M$29.9M$28.1M$29.2M$32.0M$35.5M$36.4M$31.5M$30.8M
Operating income $7.4M-$51.7M-$23.8M-$61.4M$40.1M$9.9M-$74.7M-$51.5M-$25.6M$23.5M
Interest expense $10.8M$7.6M$7.4M$1.8M$3.6M$17.9M$20.2M$17.1M$12.9M$22.4M
Pre-tax income $12.7M-$58.8M-$27.9M-$39.7M$47.6M-$17.3M-$101.3M-$68.5M-$38.4M$545.0K
Income tax $621.0K$173.0K$97.0K$1.9M$1.5M$17.0K$20.0K$562.0K$321.0K$981.0K
Net income $13.3K-$59.0K-$29.3M-$42.9M$44.2M-$15.1M-$88.9M-$60.3M-$35.0M$1.4M
EPS, basic 0.16-0.82-0.40-0.600.62-0.28-1.90-1.42-0.850.00
EPS, diluted 0.16-0.82-0.40-0.600.61-0.28-1.90-1.42-0.850.00
Shares, diluted (wtd. avg.) 75.7M73.5M73.3M71.9M72.2M58,60947.4M43,37642,74542,251

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $23.4M$35.5M$30.0M$49.5M$62.1M$48.2M$19.6M$35.1M$49.5M$64.3M
Receivables $55.1M$58.2M$58.7M$68.7M$86.9M$43.5M$74.3M$67.6M$80.3M$86.3M
Inventory $61.7M$49.9M$52.6M$66.6M$54.4M$37.9M$60.6M$57.8M$61.5M$60.1M
Total current assets $155.9M$153.1M$168.8M$199.1M$229.5M$214.0M$232.1M$168.8M$203.2M$235.2M
Property, plant and equipment $198.5M$214.7M$248.7M$239.1M$222.6M$229.5M$332.5M$482.7M$508.4M$465.2M
Goodwill ———$6.0M——————
Other intangibles $7.6M$4.5M$8.5M$9.1M$2.7M$2.7M$2.7M$2.7M$2.7M$2.7M
Total assets $388.8M$401.4M$454.2M$478.3M$485.0M$476.8M$612.5M$660.0M$720.3M$708.2M
Accounts payable $14.5M$20.4M$20.8M$28.1M————$39.7M$37.1M
Short-term debt $16.6M————$25.5M$63.0M$146.7M$20.0M$10.5M
Total current liabilities $59.1M$57.8M$65.3M$78.0M$69.6M$86.9M$160.4M$231.9M$90.7M$78.8M
Long-term debt $63.0M$92.9M$82.1M$68.4M$50.4M$71.8M$180.8M$84.8M$221.1M$188.0M
Total liabilities $143.5M$176.4M$174.7M$170.2M$139.7M$180.6M$385.4M$340.6M$336.6M$290.0M
Retained earnings -$812.1M-$824.2M-$763.9M-$734.6M-$691.8M-$736.6M-$720.2M-$630.0M-$568.5M-$532.2M
Total equity $245.2M$225.1M$279.6M$308.1M$345.2M$296.2M$227.0M$319.4M$383.7M$418.3M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $13.2M-$3.5M$22.0M$6.0M$26.8M$71.7M-$31.2M$1.6M$36.5M$37.2M
Depreciation and amortisation $25.2M$24.4M$23.1M$25.1M$23.3M$30.3M$47.9M$40.8M$38.7M$35.4M
Stock-based compensation $3.0M$4.4M$3.9M$3.3M$2.9M$2.7M$2.8M$3.4M$3.8M$2.6M
Capital expenditure $4.6M$11.1M$29.5M$37.7M$16.4M$6.6M$3.3M$15.2M$20.9M$19.2M
Investing cash flow -$7.4M-$13.5M-$33.0M-$37.7M$27.1M$23.3M-$3.3M-$15.2M-$50.4M-$14.6M
Financing cash flow -$16.4M$7.7M$7.0M$19.0M-$40.0M-$66.4M$19.0M-$9.3M-$839.0K-$9.9M
Buybacks ——$3.7M$1.3M——————

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-26-050384.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -500M 0 500M 1B 1.5B 2B Revenue, FY2016: 1.6B Gross profit, FY2016: 54.4M Net income, FY2016: 1.4M Revenue, FY2017: 1.6B Gross profit, FY2017: 5.9M Net income, FY2017: -35M Revenue, FY2018: 1.5B Gross profit, FY2018: -15.2M Net income, FY2018: -60.3M Revenue, FY2019: 1.4B Gross profit, FY2019: -9.9M Net income, FY2019: -88.9M Revenue, FY2020: 897M Gross profit, FY2020: 52.9M Net income, FY2020: -15.1M Revenue, FY2021: 1.2B Gross profit, FY2021: 67.8M Net income, FY2021: 44.2M Revenue, FY2022: 1.3B Gross profit, FY2022: -27.6M Net income, FY2022: -42.9M Revenue, FY2023: 1.2B Gross profit, FY2023: 15.7M Net income, FY2023: -29.3M Revenue, FY2024: 965.3M Gross profit, FY2024: 9.7M Net income, FY2024: -59K Revenue, FY2025: 917.9M Gross profit, FY2025: 34.9M Net income, FY2025: 13.3K FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $1.62B $1.63B $1.52B $1.42B $897.0M $1.21B $1.34B $1.22B $965.3M $917.9M
Gross profit $54.4M $5.9M -$15.2M -$9.9M $52.9M $67.8M -$27.6M $15.7M $9.7M $34.9M
Net income $1.4M -$35.0M -$60.3M -$88.9M -$15.1M $44.2M -$42.9M -$29.3M -$59.0K $13.3K

Recent filings and events

  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Officer or director change Item 5.02
  • Results announced Item 2.02
  • Results announced Item 2.02
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Shareholder vote Item 5.07

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2860

TickerCompanyMarket capP/ERevenue growth
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC $24.02B — -5.2%
LYB LyondellBasell Industries N.V. $21.47B — -9.7%
WLK WESTLAKE CORP $8.25B — -8.0%
NEU NEWMARKET CORP $8.01B 19.6x -2.2%
SXT SENSIENT TECHNOLOGIES CORP $5.65B 42.0x 3.5%
REX REX AMERICAN RESOURCES Corp $1.32B 15.9x 1.2%
GPRE Green Plains Inc. $979.9M — 16.0%
WLKP Westlake Chemical Partners LP $745.5M — 2.7%